Literature DB >> 33639249

Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art.

Antoine Andremont1, Julie Cervesi2, Pierre-Alain Bandinelli2, Fabien Vitry2, Jean de Gunzburg2.   

Abstract

Homeostasis of the intestinal microbiota is currently recognized as a major contributor to human health. Furthermore, intestinal dysbiosis is associated with a multitude of consequences, including intestinal colonization by antibiotic-resistant or pathogenic bacteria, such as Clostridioides difficile, and reduced efficacy of promising anticancer immunotherapies. By far, the most immediate and drastic exposure leading to dysbiosis is antibiotic treatment. Many attempts have been made to prevent or repair antibiotic-associated dysbiosis. Here, we review these innovations and the difficulties associated with their development.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33639249     DOI: 10.1016/j.drudis.2021.02.022

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  5 in total

1.  An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.

Authors:  Maria J G T Vehreschild; Annie Ducher; Thomas Louie; Oliver A Cornely; Celine Feger; Aaron Dane; Marina Varastet; Fabien Vitry; Jean de Gunzburg; Antoine Andremont; France Mentré; Mark H Wilcox
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.790

Review 2.  Immunomodulation Potential of Probiotics: A Novel Strategy for Improving Livestock Health, Immunity, and Productivity.

Authors:  A K M Humayun Kober; Muhammad Shahid Riaz Rajoka; Hafiza Mahreen Mehwish; Julio Villena; Haruki Kitazawa
Journal:  Microorganisms       Date:  2022-02-07

3.  Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults.

Authors:  Winston E Anthony; Bin Wang; Kimberley V Sukhum; Alaric W D'Souza; Tiffany Hink; Candice Cass; Sondra Seiler; Kimberly A Reske; Christopher Coon; Erik R Dubberke; Carey-Ann D Burnham; Gautam Dantas; Jennie H Kwon
Journal:  Cell Rep       Date:  2022-04-12       Impact factor: 9.995

4.  Probiotic characterization of Lactiplantibacillus plantarum HOM3204 and its restoration effect on antibiotic-induced dysbiosis in mice.

Authors:  S Zhang; T Wang; D Zhang; X Wang; Z Zhang; C Lim; S Lee
Journal:  Lett Appl Microbiol       Date:  2022-03-08       Impact factor: 2.813

5.  Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.

Authors:  Jia-Feng Wang; Chang-Yi Shi; Hua-Zhong Ying
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.